Real World Data Leverage long-running EHR data spanning millions of lives with advanced analytics (SAS/STAT) and systems such as Cerner and Optum to deliver robust HEOR and real-world evidence. This enables payer-ready evidence generation, pricing and access strategy support, and stronger regulatory submissions. Sell to mid-size to large pharma, biotech, and medical device companies seeking data-driven clinical and market access validation; offer pilots or bundled HEOR engagements to demonstrate ROI.

One Stop Partner Offer an end-to-end life sciences advisory suite including business and clinical strategy, HEOR, medical communications, regulatory strategy, and financial advisory. Position BSP as a cost-efficient, single-source partner capable of lifecycle coverage, accelerating procurement and reducing vendor fragmentation. Target startups and mid-market firms with bundled offerings and phased engagements, and leverage existing client relationships for cross-sell across pharma, devices, and diagnostics.

Global Regulatory Leverage multinational, multicultural capabilities and global regulatory experience to support cross-border submissions and market access planning. This appeals to companies expanding internationally or seeking harmonized evidence generation across regions. Approach global launches and device/diagnostics players with end-to-end regulatory readiness, cross-regional HEOR data needs, and payer strategy support.

Credibility Partnerships Recent data partnerships and clinical recognition (market data distribution agreement and an ISICEM poster award) bolster BSP’s credibility for data-driven advisory and evidence generation. Use these assets to win RFPs, pursue data licensing or co-marketing deals, and position BSP as a trusted partner for real-world evidence, market access benchmarking, and competitive analytics.

Targeted Outreach With a client base spanning startups to Fortune 100 firms in pharma, medical devices, and diagnostics, BSP offers scalable upsell opportunities and a path to growth for growth-stage companies needing strategic support across evidence generation, regulatory, and financial advisory. Action steps include mapping C-suite and function heads (regulatory, market access, payer strategy) at target firms and launching account-based marketing and bundled service proposals.